ICH E8(R1) General Considerations for Clinical Studies

This revised guidance from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) describes internationally accepted principles and practices in the design and conduct of clinical studies of drug and biological products. The guidance incorporates the most current concepts achieving fit-for-purpose data quality as one of the essential considerations for all clinical trials.

Download the full guidance here

FDA Guidance on Providing Regulatory Submissions in Electronic and Non-Electronic Format

The U.S. Food & Drug Administration (FDA) issued a guidance on providing regulatory submissions in electronic and non-electronic format. This guidance pertains to submissions of promotional materials for human prescription drugs to the FDA made by manufacturers, packers, and distributors, whether the applicant or an entity acting on behalf of the applicant. Specifically, this guidance pertains to submissions made to the Office of Prescription Drug Promotion (OPDP) in the Center for Drug Evaluation and Research (CDER) and the Advertising and Promotional Labeling Branch (APLB) in the Center for Biologics Evaluation and Research (CBER). This guidance also explains certain aspects of electronic submission of promotional materials in module 1 of the electronic common technical document (eCTD).

Read the full guidance here